BUILD A LEGACY OF SUPERIOR HEART FAILURE OUTCOMES1*
How your patients live their lives depends on the LVAD you choose. HeartMate 3TM LVAD with Full MagLevTM Flow Technology delivers unprecedented† survival and safety outcomes as demonstrated in the MOMENTUM 3 Trial at 2 years.1* With the HeartMate 3 LVAD, you can go above and beyond to make a meaningful difference in patient lives.
THE HIGHEST PUBLISHED 2-YEAR SURVIVAL RATE AND THE LOWEST PUBLISHED STROKE AND THROMBOSIS RATES FOR CONTINUOUS-FLOW LVADS1-5
Read more about the Clinical Evidence for HeartMate 3 LVAD.
COMPREHENSIVE HEART FAILURE MANAGEMENT PORTFOLIO
The HeartMate 3™ LVAD is part of our heart failure management portfolio. Our vision is to transform the treatment of heart failure by designing technology that delivers excellent clinical outcomes and improves workflow and efficiency. Read more about the portfolio and our approach to heart failure management.